Modulation of cell proliferation in rat liver cell cultures by new calix[4]arenes

References

• McCance RA, Widdowson EM. Absorption and excretion of iron. Lancet 1937; ii: 680–684
   Google Scholar
• Deugnier Y, Charalambous P, Le Quilleuc D, Turlin B, Searle J, Brissot P, Powell LW, Halliday JW. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients. Hepatology 1993; 18: 1363–1369
   PubMed Web of Science ®Google Scholar
• Hsing AW, McLaughlin JK, Olsen JH, Mellemkjar L, Wacholder S, Fraumeni JF. Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark. Int J Cancer 1995; 60: 160–162
   PubMed Web of Science ®Google Scholar
• Chenoufi N, Loréal O, Drénou B, Cariou S, Hubert N, Leroyer P, Brissot P, Lescoat G. Iron may induce DNA synthesis and repair in rat hepatocytes stimulated by EGF/pyruvate. J Hepatol 1995; 26: 650–658
   Web of Science ®Google Scholar
• Hann HWL, Stahlhut MW, Blumberg BS. Iron nutrition and tumor growth: decreased tumor growth in iron deficient mice. Cancer Res 1988; 48: 4168–4170
   PubMed Web of Science ®Google Scholar
• Thompson HJ, Kennedy K, Witt M, Juzefyk J. Effect of dietary iron deficiency or excess on the induction of mammary carcinogenenis by 1-methyl-1-nitrosourea. Carcinogenesis 1991; 12: 111–114
   PubMed Web of Science ®Google Scholar
• Tarao K, Shimizu A, Ohkawa S, Harada M, Ito Y, Tamai S, Kuni Y, Okamoto N, Inoue T, Kanisawa M. Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis. Gastroenterol 1992; 103: 595–600
   PubMed Web of Science ®Google Scholar
• Ballardini G, Groff P, Zoli M, Bianchi G, Giostra F, Francesconi R, Lenzi M, Zauli D, Cassani F, Bianchi F. Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferation. J Hepatol 1994; 20: 218–222
   PubMed Web of Science ®Google Scholar
• Soyano A, Chinea M, Romano EL. The effect of desferrioxamine on the proliferative response of rat lymphocytes stimulated with various mitogens in vitro. Immunopharmacol 1984; 8: 163–169
   PubMed Web of Science ®Google Scholar
• Polson RJ, Jenkins R, Lombard M, Williams AC, Roberts S, Nouri-Aria K, Williams R, Bomford A. Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine. Immunology 1990; 71: 176–181
   PubMed Web of Science ®Google Scholar
• Richardson DR, Milnes K. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone. Blood 1997; 89: 3025–3038
   PubMed Web of Science ®Google Scholar
• Chenoufi N, Baffet G, Drénou B, Cariou S, Desille M, Clément B, Brissot P, Lescoat G, Loréal O. Deferoxamine arrests in vitro the proliferation of porcine hepatocyte in G1 phase of the cell cycle. Liver 1997; 18: 60–67
   Google Scholar
• Chenoufi N, Drénou B, Loréal O, Pigeon C, Brissot P, Lescoat G. Antiproliferative effect of deferiprone on the HepG2 cell line. Biochem Pharmacol 1998; 56: 431–437
   PubMed Web of Science ®Google Scholar
• Rakba N, Loyer P, Gilot D, Delcros JG, Glaise D, Baret P, Pierre JL, Brissot P, Lescoat G. Antiproliferative and apoptotic effects of O-Trensox, a new synthetic iron chelator, on differentiated human hepatoma cell lines. Carcinogenesis 2000; 21: 943–951
   PubMed Web of Science ®Google Scholar
• Brodie C, Siriwardana G, Lucas J, Schleicher R, Terada N, Szepesi A, Gelfand E, Seligman P. Neuroblastoma sensitivity to growth inhibition by desferrioxamine: evidence for a block in G1 phase of the cell cycle. Cancer Res 1993; 53: 3968–3975
   PubMed Web of Science ®Google Scholar
• Glickstein H, Breuer W, Loyevsky M, Konijn AM, Shanzer A, Cabantchik ZI. Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells. Blood 1996; 87: 4871–4878
   PubMed Web of Science ®Google Scholar
• Valle P, Timeus F, Piglione M, Rosso P, di Montezemolo LC, Crescenzio N, Marranca D, Ramenghi U. Effect of different exposures to desferrioxamine on neuroblastoma cell lines. Pediatr Hematol Oncol 1995; 12: 439–446
   PubMed Web of Science ®Google Scholar
• Olivieri NF, Koren G, Matsui D, Liu PP, Blendis L, Cameron R, McClelland RA, Templeton DM. Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermedia. Blood 1992; 79: 2741–2748
   PubMed Web of Science ®Google Scholar
• Al-Refaie FN, Wonke B, Hoffbrand AV, Wickens DG, Nortey P, Kontoghiorges GJ. Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major. Blood 1992; 80: 593–599
   PubMed Web of Science ®Google Scholar
• Collins AF, Fassos FF, Stobie S, Lewis N, Shaw D, Fry M, Templeton DM, McClelland RA, Koren G, Olivieri NF. Iron-balance and dose-response studies of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients with sickle cell disease. Blood 1994; 83: 2329–2333
   PubMed Web of Science ®Google Scholar
• Porter JB, Davis BA. Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. Best Pract Res Clin Haematol 2002; 15: 329–368
   PubMed Web of Science ®Google Scholar
• Caris C, Baret P, Beguin C, Serratrice G, Pierre JL, Laulhere JP. Metabolization of iron by plant cells using O-Trensox, a high-affinity abiotic iron-chelating agent. Biochem J 1995; 312: 879–885
   PubMed Web of Science ®Google Scholar
• Unpublished results.
   Google Scholar
• Gutsche CD. Calixarenes revisited, Monographs in Supramolecular Chemistry. JF Stoddart. The Royal Society of Chemistry, London, UK 1998
   Google Scholar
• Vicens J, Böhmer V. Calixarenes, A Versatile Class of Macrocyclic Compounds; Topics in Inclusion Science. J Vicens, V Böhmer. Kluwer Academic Press, Dordrecht, The Netherlands 1991
   Google Scholar
• Böhmer V. Calixarenes, macrocycles with (almost) unlimited possibilities. Angew Chem Int Ed Engl 1995; 34: 713–745
   Web of Science ®Google Scholar
• Sansone F, Segura M, Ungaro R. Calixarenes in Bioorganic and Biomimetic Chemistry. Calixarenes 2001, Z Asfari, V Böhmer, J Harrowfield, J Vicens. Kluwer Academic Publishers, Dordrecht, The Netherlands 2001; 496–512
   Google Scholar
• Lamartine R, Tsukada M, Shirata A. Antimicrobial activity of calixarenes. C R Chimie 2002; 5: 1–7
   Web of Science ®Google Scholar
• Da Silva E, Ficheux D, Coleman AW. Anti-thrombotic activity of water-soluble calix[n]arenes. J Inclusion Phenom Macrocyclic Chem 2005; 52: 201–206
   Web of Science ®Google Scholar
• Guillon J, Léger JM, Sonnet P, Jarry C, Robba M. Synthesis of cone, partial-cone and 1,3-alternate 25,27-bis[1-(2-ethyl)hexyl]- and 25,27-bis[1-(2-tert-butoxy)ethyl]calix[4]arene-crown-6 conformers as potential selective cesium extractants. J Org Chem 2000; 65: 8283–8289
   PubMed Web of Science ®Google Scholar
• Guillon J, Sonnet P, Malval JP, Massip S, Gosse I, Léger JM, Lapouyade R, Rochette J, Monti JP, Jarry C. Synthesis and cesium binding affinity of new 25,27-bis(alkyloxy)calix[4]arene-crown-6 conformers in relation to the alkyl pendent moiety. Supramol Chem 2002; 14: 437–450
   Web of Science ®Google Scholar
• Guillon J, Léger JM, Dapremont C, Denis LA, Sonnet P, Massip S, Jarry C. First synthesis of 1,3-alternate 25,27-dialkyloxy-5,17-diarylcalix[4]arenes-crown-6 as new cesium selective extracants by Suzuki cross-coupling reaction. Supramol Chem 2004; 16: 319–329
   Web of Science ®Google Scholar
• Deschatrette J, Weiss MC. Characterization of differentiated clones from a rat hepatoma. Biochimie 1974; 56: 1603–1611
   PubMed Web of Science ®Google Scholar
• Gaboriau F, Delcros JG, Moulinoux JP. A simple assay for the measurement of plasma antioxidant status using spontaneous autoxidation of homovanillic acid. J Pharmacol Toxicol Methods 2002; 47: 33–43
   PubMed Web of Science ®Google Scholar
• Aoki I, Sakaki T, Shinkai S. A new metal sensory system based on intramolecular fluorescence quenching on the ionophoric calix[4]arene ring. J Chem Soc, Chem Commun 1992; 730–732
   Google Scholar
• Rudkevich DM, Verboom W, Reinhoudt DN. Calix[4]arene salenes: A bifunctional receptor for NaH2PO4. J Org Chem 1994; 59: 3683–3686
   Web of Science ®Google Scholar
• Kubo Y, Tokit S, Kojima Y, Osano YT, Matsuzaki T. A new family of indoaniline-derived calix[4]arenes: synthesis and optical recognition properties as a chromogenic receptor. J Org Chem 1996; 61: 3758–3765
   PubMed Web of Science ®Google Scholar
• Arena G, Casnati A, Mirone L, Sciotto D, Ungaro R. A new water-soluble calix[4]arene ditopic receptor rigidified by microsolvation: Acid-base and inclusion properties. Tetrahedron Lett 1997; 38: 1999–2002
   Web of Science ®Google Scholar
• Collins EM, McKervey A, Harris SJ. Molecular receptors with calix[4]arene substructure. Synthesis of derivatives with mixed ligating functional groups. J Chem Soc, Perkin Trans 1 1989; 372–374
   Google Scholar
• Collins EM, McKervey A, Madigan E, Moran MB, Owens M, Ferguson G, Harris SJ. Chemically modified calix[4]arenes. Regioselective synthesis of 1,3-(distal) derivatives and related compounds. X-ray crystal structure of a diphenol-dinitrile. J Chem Soc, Perkin Trans 1 1991; 3137–3142
   Google Scholar
• Franceschini N, Da Nascimento S, Sonnet P, Guillaume D. Efficient enantioselective synthesis of 2-substituted thiomorpholin-3-ones. Tetrahedron: Asymmetry 2003; 14: 3401–3405
   Google Scholar